menu

Diving Into Fixed Duration Therapy in CLL: Opportunities & Challenges

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Diving Into Fixed Duration Therapy in CLL: Opportunities & Challenges

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Dr. Jacob Sands is joined by Dr. Elizabeth Brém, an Assistant Professor in the Division of Hematology/Oncology at the University of California Irvine School of Medicine to explore opportunities and challenges with fixed duration therapy for patients with chronic lymphocytic leukemia.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Dr. Jacob Sands is joined by Dr. Elizabeth Brém, an Assistant Professor in the Division of Hematology/Oncology at the University of California Irvine School of Medicine to explore opportunities and challenges with fixed duration therapy for patients with chronic lymphocytic leukemia.

Facebook Comments

Schedule4 Dec 2021
Webpack App